Commercial versus native surfactants: Surface activity, molecular components, and the effect of calcium

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 I, 2000, Pages 1524-1533

  Bernhard, W ^a   Mottaghian, J ^a   Gebert, A ^a   Rau, G A ^a   Von der Hardt, H ^a   Poets, C F ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; CALCIUM; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT;

ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CRYSTAL STRUCTURE; DRUG POTENCY; LUNG ALVEOLUS SURFACE TENSION; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0033773963     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.4.9908104     Document Type: Article

References (51)

1. Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactant
2. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant-associated hydrophobic protein SP-B
3. Effect of fibrin ogen degradation products and lung ground substance on surfactant function
4. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
5. Inhibition of pulmonary surfactant function by phosphollpases
6. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants
7. Surface tension of therapeutic surfactants (Exosurf Neonatal Infasurf, and Survanta) as evaluated by standard methods and criteria
8. Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations
9. Surface tension measurement in surfactant preparations and tracheal aspirates of newborns with pulsating bubble surfactometer
10. Dynamic surface tension of surfactant TA: Experiments and theory
11. Biophysical characterization and modeling of lung surfactant components
12. Influence of phospholipid composition on the properties of reconstituted surfactants
13. Content of dipalmitoyl phosphatidylcholine in lung surfactant: Ramifications for surface activity
14. Alveolar surface tension and lung surfactant
15. Pharmacology of exogenous surfactant
16. Das atemnotsyndrom (ANS)epidemiologie, pathophysiologie, klinik und prinzipien der surfactanttherapie
17. Conductive airway surfactant: Surface tension function, biochemical composition and possible alveolar origin
18. Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age
19. Pulsating bubble technique for evaluating pulmonary surfactant
20. A rapid method of total lipid extraction and purification
21. Phosphorus assay in column chromatography
22. Method for the sensitive analysis of individual molecular species of phosphatidylcholine by high-performance liquid chromatography using post column fluorescence detection
23. Quantitative analysis of pulmonary surfactant proteins B and C
24. Fluorimetric assay of proteins in the nanogram range
25. Fixation
26. Stereological principles for morphometry in electron microscopic cytology
27. Calcium increases in pulmonary alveolar fluid in lambs at birth
28. Dosis-Wirkungs-Beziehungen
29. Molekulare diagnostik der surfactantstorungen
30. Interspecies variation in lung lavage and tissue saturated phosphatidylcholine
31. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits
32. The pulmonary surfactant system
33. Characteristics of surfactant from SP-A-deficient mice
34. Role of bovine pulmonary surfactantassociated proteins in the surface-active property of phospholipid mixtures
35. Influence of surfactant proteins on potency and efficacy of bovine and alveolar proteinosis surfactant
36. A synthetic segment of surfactant protein A: Structure, in vitro surface activity, and in vivo efficacy
37. Active surfactant in pharyngeal aspirates of term neonates: Lipid biochemistry and surface tension function
38. Structure-function relationships of bovine surfactant proteins: SP-B and SP-C
39. Biophysical and biological activity of a synthetic 8.6-kDa hydrophobic pulmonary surfactant protein SP-B
40. Tracheal aspirate surface tension in babies with hyaline membrane disease: Effect of synthetic surfactant replacement
41. The fate of exogenous surfactant in neonates with respiratory distress syndrome
42. Role of calcium ions in the structure and function of pulmonary surfactant
43. Overview of clinical trials comparing natural and synthetic surfactants
44. Reassembly of lipid-protein complexes of pulmonary surfactant: Proposed mechanism of interaction
45. Interactions of the low molecular weight group of surfactant-associated proteins (SP 5-18) with pulmonary surfactant lipids
46. Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B and SP-C
47. Effect of pulmonary surfactant protein B and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine
48. Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling
49. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge
50. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo
51. Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits